Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cumulative Live Birth Rate With eSET After In-vitro Fertilization With Preim-plantation Genetic Screening by Next Generation Sequencing Versus Conventional In-vitro Fertilization: A Pragmatic Randomized Controlled Clinical Trial

NCT03118141 is registered in ClinicalTrials.gov with Chen Zi-Jiang as lead sponsor.

NCT NCT03118141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03118141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cumulative Live Birth Rate With eSET After In-vitro Fertilization With Preim-plantation Genetic Screening by Next Generation Sequencing Versus Conventional In-vitro Fertilization: A Pragmatic Randomized Controlled Clinical Trial
Lead sponsor
Chen Zi-Jiang
Phase
Not applicable
Overall status
Unknown status
Start date
July 9, 2017
Completion date
June 30, 2020
Enrollment
1,215 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility